186 related articles for article (PubMed ID: 31311869)
1. PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.
Lopez ML; Lo M; Kung JE; Dudkiewicz M; Jang GM; Von Dollen J; Johnson JR; Krogan NJ; Pawłowski K; Jura N
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15495-15504. PubMed ID: 31311869
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.
Ha BH; Boggon TJ
J Biol Chem; 2018 Feb; 293(5):1642-1650. PubMed ID: 29212708
[TBL] [Abstract][Full Text] [Related]
3. Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.
Hou J; Nguyen EV; Surudoi M; Roy MJ; Patel O; Lucet IS; Ma X; Daly RJ
Sci Signal; 2022 Feb; 15(722):eabj3554. PubMed ID: 35192416
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling.
Abassi YA; Vuori K
EMBO J; 2002 Sep; 21(17):4571-82. PubMed ID: 12198159
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.
Torosyan H; Paul MD; Forget A; Lo M; Diwanji D; Pawłowski K; Krogan NJ; Jura N; Verba KA
Nat Commun; 2023 Jun; 14(1):3543. PubMed ID: 37336883
[TBL] [Abstract][Full Text] [Related]
6. Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.
Roy MJ; Surudoi MG; Kropp A; Hou J; Dai W; Hardy JM; Liang LY; Cotton TR; Lechtenberg BC; Dite TA; Ma X; Daly RJ; Patel O; Lucet IS
Nat Commun; 2023 Jun; 14(1):3542. PubMed ID: 37336884
[TBL] [Abstract][Full Text] [Related]
7. SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase.
Ounoughene Y; Fourgous E; Boublik Y; Saland E; Guiraud N; Recher C; Urbach S; Fort P; Sarry JE; Fesquet D; Roche S
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944965
[TBL] [Abstract][Full Text] [Related]
8. The PEAK family of pseudokinases, their role in cell signalling and cancer.
Patel O; Roy MJ; Murphy JM; Lucet IS
FEBS J; 2020 Oct; 287(19):4183-4197. PubMed ID: 31599110
[TBL] [Abstract][Full Text] [Related]
9. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation.
Lecointre C; Simon V; Kerneur C; Allemand F; Fournet A; Montarras I; Pons JL; Gelin M; Brignatz C; Urbach S; Labesse G; Roche S
Structure; 2018 Apr; 26(4):545-554.e4. PubMed ID: 29503074
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Dab1 and CrkII is promoted by Reelin signaling.
Chen K; Ochalski PG; Tran TS; Sahir N; Schubert M; Pramatarova A; Howell BW
J Cell Sci; 2004 Sep; 117(Pt 19):4527-36. PubMed ID: 15316068
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells.
Petit V; Boyer B; Lentz D; Turner CE; Thiery JP; Vallés AM
J Cell Biol; 2000 Mar; 148(5):957-70. PubMed ID: 10704446
[TBL] [Abstract][Full Text] [Related]
13. Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.
Saleh T; Jankowski W; Sriram G; Rossi P; Shah S; Lee KB; Cruz LA; Rodriguez AJ; Birge RB; Kalodimos CG
Nat Chem Biol; 2016 Feb; 12(2):117-23. PubMed ID: 26656091
[TBL] [Abstract][Full Text] [Related]
14. CrkII regulates focal adhesion kinase activation by making a complex with Crk-associated substrate, p130Cas.
Iwahara T; Akagi T; Fujitsuka Y; Hanafusa H
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17693-8. PubMed ID: 15598735
[TBL] [Abstract][Full Text] [Related]
15. Binding Mechanism of the N-Terminal SH3 Domain of CrkII and Proline-Rich Motifs in cAbl.
Bhatt VS; Zeng D; Krieger I; Sacchettini JC; Cho JH
Biophys J; 2016 Jun; 110(12):2630-2641. PubMed ID: 27332121
[TBL] [Abstract][Full Text] [Related]
16. Modulation of HeLa cells spreading by the non-receptor tyrosine kinase ACK-2.
Coon M; Herrera R
J Cell Biochem; 2002; 84(4):655-65. PubMed ID: 11835391
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration.
Takino T; Tamura M; Miyamori H; Araki M; Matsumoto K; Sato H; Yamada KM
J Cell Sci; 2003 Aug; 116(Pt 15):3145-55. PubMed ID: 12799422
[TBL] [Abstract][Full Text] [Related]
18. Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.
Watanabe T; Tsuda M; Makino Y; Konstantinou T; Nishihara H; Majima T; Minami A; Feller SM; Tanaka S
Cell Res; 2009 May; 19(5):638-50. PubMed ID: 19350053
[TBL] [Abstract][Full Text] [Related]
19. Abl functions as a negative regulator of Met-induced cell motility via phosphorylation of the adapter protein CrkII.
Cipres A; Abassi YA; Vuori K
Cell Signal; 2007 Aug; 19(8):1662-70. PubMed ID: 17399949
[TBL] [Abstract][Full Text] [Related]
20. Immunophilins control T lymphocyte adhesion and migration by regulating CrkII binding to C3G.
Nath PR; Dong G; Braiman A; Isakov N
J Immunol; 2014 Oct; 193(8):3966-77. PubMed ID: 25225668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
